Clinical Investigation on the Impact of Cannabis Abuse on Thyroid Hormones and Associated Psychiatric Manifestations in the Male Population
- PMID: 34925083
- PMCID: PMC8678041
- DOI: 10.3389/fpsyt.2021.730388
Clinical Investigation on the Impact of Cannabis Abuse on Thyroid Hormones and Associated Psychiatric Manifestations in the Male Population
Abstract
Cannabis abuse is a common public health issue and may lead to considerable adverse effects. Along with other effects, the dependence on cannabis consumption is a serious problem which has significant consequences on biochemical and clinical symptoms. This study intends to evaluate the harmful effects of the use of cannabis on thyroid hormonal levels, cardiovascular indicators, and psychotic symptoms in the included patients. This prospective multicenter study was conducted on cannabis-dependent patients with psychotic symptoms (n = 40) vs. healthy control subjects (n = 40). All participants were evaluated for psychiatric, biochemical, and cardiovascular physiological effects. Patients were selected through Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria and urine samples, exclusively for the evaluation of cannabis presence. Serum thyroid stimulating hormone (TSH), T3, and T4 levels were measured using the immunoassay technique. Patients were assessed for severity of depressive, schizophrenic, and manic symptoms using international ranking scales. Various quantifiable factors were also measured for the development of tolerance by cannabis. Among the patients of cannabis abuse, 47.5% were found with schizophrenia, 20% with schizoaffective symptoms, 10% with manic symptoms, and 22.5% with both manic and psychotic symptoms. In the group-group and within-group statistical analysis, the results of thyroid hormones and cardiovascular parameters were non-significant. The psychiatric assessment has shown highly significant (p < 0.001) difference of positive, negative, general psychopathology, and total scores [through Positive and Negative Syndrome Scale (PANSS) rating scales] in patients vs. the healthy control subjects. The study revealed that cannabis abuse did not significantly alter thyroid hormones and cardiovascular parameters due to the development of tolerance. However, the cannabis abuse might have a significant contributing role in the positive, negative, and manic symptoms in different psychiatric disorders.
Keywords: cannabis; cardiovascular parameters; dependence; psychiatric symptoms; thyroid hormones.
Copyright © 2021 Muzaffar, Ullah, Subhan, Nazar, Hussain, Khuda, Khan, Khusro, Sahibzada, Albogami, El-Shehawi, Emran, Javed and Ali.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
[Cannabis and schizophrenia: demographic and clinical correlates].Encephale. 2003 Jan-Feb;29(1):11-7. Encephale. 2003. PMID: 12640322 French.
-
Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients.Compr Psychiatry. 2010 Jan-Feb;51(1):37-41. doi: 10.1016/j.comppsych.2009.03.008. Epub 2009 May 6. Compr Psychiatry. 2010. PMID: 19932824
-
[Search association between cannabis abuse and bipolar disorder: A study on a sample of patients hospitalized for bipolar disorder].Encephale. 2018 Feb;44(1):14-21. doi: 10.1016/j.encep.2016.08.005. Epub 2016 Oct 11. Encephale. 2018. PMID: 27745717 French.
-
[Cannabis abuse in patients with psychiatric disorders: an update to old evidence].Braz J Psychiatry. 2010 May;32 Suppl 1:S41-5. Braz J Psychiatry. 2010. PMID: 20512269 Review. Portuguese.
-
[Alpha-interferon and mental disorders].Encephale. 2001 Jul-Aug;27(4):308-17. Encephale. 2001. PMID: 11686052 Review. French.
Cited by
-
Comparison of pre-treatment with different diluted sufentanil in reducing propofol injection pain in gastrointestinal endoscopy: A randomized controlled study.PLoS One. 2025 May 29;20(5):e0325113. doi: 10.1371/journal.pone.0325113. eCollection 2025. PLoS One. 2025. PMID: 40440342 Free PMC article. Clinical Trial.
-
Green Smoke, Red Flag: Cannabis and the Risk of Orbitopathy and Dermopathy in Thyrotoxicosis.Cureus. 2023 May 16;15(5):e39092. doi: 10.7759/cureus.39092. eCollection 2023 May. Cureus. 2023. PMID: 37378109 Free PMC article.
-
Association between free thyroxine levels and clinical phenotype in first-episode psychosis: a prospective observational study.PeerJ. 2023 Jun 2;11:e15347. doi: 10.7717/peerj.15347. eCollection 2023. PeerJ. 2023. PMID: 37283900 Free PMC article.
References
LinkOut - more resources
Full Text Sources